TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Investing.com

Amgen Stock Momentum Builds as Institutions Return to Buying Mode

Investing.com Logo Investing.com By Chris Markoch
Amgen Stock Momentum Builds as Institutions Return to Buying Mode

Amgen reported strong quarterly earnings, beating revenue and EPS estimates, with robust performance across drug portfolios and positive momentum signaling potential new stock highs.

Insights
MSFT   positive

Third in $3 trillion club with $3.8 trillion market cap


AMGN   positive

Delivered 6.89% revenue growth, beat earnings estimates by 12.57%, raised full-year guidance, showed strong performance across multiple drug segments, and demonstrated institutional buying interest with stock surging 7.7%